Selected research
Industry Research
Adenosylcobalamin Tablets Industry Research Report 2026
Market perspective
The global Adenosylcobalamin Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Adenosylcobalamin Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Adenosylcobalamin Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Adenosylcobalamin Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Adenosylcobalamin Tablets include Fujian Gutian Pharmaceutical Co., Ltd., Sinopharm Group Rongsheng Pharmaceutical Co., Ltd., Hebei Bianque Pharmaceutical Co., Ltd., North China Pharmaceutical Co., Ltd., North China Pharmaceutical Hebei Huanuo Co., Ltd., Ningxia Zhouyang Pharmaceutical Co., Ltd., Shijiazhuang Kangli Pharmaceutical Co., Ltd. and Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Adenosylcobalamin Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Adenosylcobalamin Tablets Market by Company
Fujian Gutian Pharmaceutical Co., Ltd.
Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
Hebei Bianque Pharmaceutical Co., Ltd.
North China Pharmaceutical Co., Ltd.
North China Pharmaceutical Hebei Huanuo Co., Ltd.
Ningxia Zhouyang Pharmaceutical Co., Ltd.
Shijiazhuang Kangli Pharmaceutical Co., Ltd.
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
Adenosylcobalamin Tablets Segment by Type
Boxed
Bottled
Adenosylcobalamin Tablets Segment by Application
Hospital
Clinic
Other
Adenosylcobalamin Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adenosylcobalamin Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adenosylcobalamin Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adenosylcobalamin Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Adenosylcobalamin Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Adenosylcobalamin Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Adenosylcobalamin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Boxed
- Bottled
Applications
- Hospital
- Clinic
- Other
Companies covered
- Fujian Gutian Pharmaceutical Co., Ltd.
- Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
- Hebei Bianque Pharmaceutical Co., Ltd.
- North China Pharmaceutical Co., Ltd.
- North China Pharmaceutical Hebei Huanuo Co., Ltd.
- Ningxia Zhouyang Pharmaceutical Co., Ltd.
- Shijiazhuang Kangli Pharmaceutical Co., Ltd.
- Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Adenosylcobalamin Tablets Market Size (2021-2032)
- 2.2.2 Global Adenosylcobalamin Tablets Sales (2021-2032)
- 2.2.3 Global Adenosylcobalamin Tablets Market Average Price (2021-2032)
- 2.3 Adenosylcobalamin Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Boxed
- 2.3.3 Bottled
- 2.4 Adenosylcobalamin Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Adenosylcobalamin Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Adenosylcobalamin Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Adenosylcobalamin Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Adenosylcobalamin Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Adenosylcobalamin Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Adenosylcobalamin Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Adenosylcobalamin Tablets, Product Type & Application
- 3.8 Global Manufacturers of Adenosylcobalamin Tablets, Established Date
- 3.9 Global Adenosylcobalamin Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Fujian Gutian Pharmaceutical Co., Ltd.
- 4.1.1 Fujian Gutian Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Fujian Gutian Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Fujian Gutian Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.1.5 Fujian Gutian Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
- 4.2.1 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Company Information
- 4.2.2 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Business Overview
- 4.2.3 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.2.5 Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. Recent Developments
- 4.3 Hebei Bianque Pharmaceutical Co., Ltd.
- 4.3.1 Hebei Bianque Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Hebei Bianque Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hebei Bianque Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.3.5 Hebei Bianque Pharmaceutical Co., Ltd. Recent Developments
- 4.4 North China Pharmaceutical Co., Ltd.
- 4.4.1 North China Pharmaceutical Co., Ltd. Company Information
- 4.4.2 North China Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 North China Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.4.5 North China Pharmaceutical Co., Ltd. Recent Developments
- 4.5 North China Pharmaceutical Hebei Huanuo Co., Ltd.
- 4.5.1 North China Pharmaceutical Hebei Huanuo Co., Ltd. Company Information
- 4.5.2 North China Pharmaceutical Hebei Huanuo Co., Ltd. Business Overview
- 4.5.3 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 North China Pharmaceutical Hebei Huanuo Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.5.5 North China Pharmaceutical Hebei Huanuo Co., Ltd. Recent Developments
- 4.6 Ningxia Zhouyang Pharmaceutical Co., Ltd.
- 4.6.1 Ningxia Zhouyang Pharmaceutical Co., Ltd. Company Information
- 4.6.2 Ningxia Zhouyang Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ningxia Zhouyang Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.6.5 Ningxia Zhouyang Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Shijiazhuang Kangli Pharmaceutical Co., Ltd.
- 4.7.1 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.7.5 Shijiazhuang Kangli Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
- 4.8.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
- 4.8.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
- 4.8.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Adenosylcobalamin Tablets Product Portfolio
- 4.8.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
5 Global Adenosylcobalamin Tablets Market Scenario by Region
- 5.1 Global Adenosylcobalamin Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Adenosylcobalamin Tablets Sales by Region: 2021-2032
- 5.2.1 Global Adenosylcobalamin Tablets Sales by Region: 2021-2026
- 5.2.2 Global Adenosylcobalamin Tablets Sales by Region: 2027-2032
- 5.3 Global Adenosylcobalamin Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Adenosylcobalamin Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Adenosylcobalamin Tablets Revenue by Region: 2027-2032
- 5.4 North America Adenosylcobalamin Tablets Market Facts & Figures by Country
- 5.4.1 North America Adenosylcobalamin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Adenosylcobalamin Tablets Sales by Country (2021-2032)
- 5.4.3 North America Adenosylcobalamin Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Adenosylcobalamin Tablets Market Facts & Figures by Country
- 5.5.1 Europe Adenosylcobalamin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Adenosylcobalamin Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Adenosylcobalamin Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Adenosylcobalamin Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Adenosylcobalamin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Adenosylcobalamin Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Adenosylcobalamin Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Adenosylcobalamin Tablets Market Facts & Figures by Country
- 5.7.1 South America Adenosylcobalamin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Adenosylcobalamin Tablets Sales by Country (2021-2032)
- 5.7.3 South America Adenosylcobalamin Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Adenosylcobalamin Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Adenosylcobalamin Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Adenosylcobalamin Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Adenosylcobalamin Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Adenosylcobalamin Tablets Sales by Type (2021-2032)
- 6.1.1 Global Adenosylcobalamin Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Adenosylcobalamin Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Adenosylcobalamin Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Adenosylcobalamin Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Adenosylcobalamin Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Adenosylcobalamin Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Adenosylcobalamin Tablets Sales by Application (2021-2032)
- 7.1.1 Global Adenosylcobalamin Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Adenosylcobalamin Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Adenosylcobalamin Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Adenosylcobalamin Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Adenosylcobalamin Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Adenosylcobalamin Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Adenosylcobalamin Tablets Value Chain Analysis
- 8.1.1 Adenosylcobalamin Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Adenosylcobalamin Tablets Production Mode & Process
- 8.2 Adenosylcobalamin Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Adenosylcobalamin Tablets Distributors
- 8.2.3 Adenosylcobalamin Tablets Customers
9 Global Adenosylcobalamin Tablets Analyzing Market Dynamics
- 9.1 Adenosylcobalamin Tablets Industry Trends
- 9.2 Adenosylcobalamin Tablets Industry Drivers
- 9.3 Adenosylcobalamin Tablets Industry Opportunities and Challenges
- 9.4 Adenosylcobalamin Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst